Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SLG2 Inhibitors 

In this six-part video series, KDIGO 2024 CKD Guideline Work Group Member Dr. Michael Shlipak (University of California San Francisco, United States) shares insights for primary care physicians from the KDIGO 2024 CKD Guideline.
In this video, Part 6 of 6, Dr. Shlipak addresses SLG2 inhibitors.
To download the KDIGO CKD Guideline, Executive Summary, and for related resources, please visit the KDIGO CKD Guideline Website: kdigo.co/CKD-Guideline-Website.